Oral Dosage Forms Market Outlook (6th Ed.)

Oral dosage forms remain the dominant drug delivery method and continue to advance through new technologies. This report gives marketing and commercial teams clear, data-driven insight into market trends, outsourcing behaviors, CDMO selection drivers, and the competitive landscape—helping you sharpen positioning and communicate differentiation.

What you will learn:

Market Dynamics:

• Shifts in oral dose project volume and CDMO usage
• Utilization, share, and spending across 15 dosage forms
• High growth dosage form opportunities

Trends & Growth Drivers:

• Life cycle management strategies
• What’s driving oral dose market expansion
• Technology and capability demand outlook

Geographic Outsourcing Insights:

• Where developers are sending work
• Emerging market CDMO usage rates
• Benefits and risks of emerging market CDMOs

How Customers Choose CDMOs:

• Selection criteria and key decision influencers
• Satisfaction drivers and reasons bids are lost
• How preferred provider relationships are managed

Competitive Landscape:

• Brand familiarity and usage
• Market leaders and customer preferences
• Proposal volume and cost perceptions

Respondents were required to pass several screening criteria to qualify and participate in this survey:

• Must work at a biopharmaceutical company
• Must have responsibilities in at least one of the following categories: executive management, clinical trial manufacturing, commercial manufacturing, drug product manufacturing, outsourcing/purchasing management, or supply chain
• Must have significant influence over outsourced oral dose manufacturing
• Must have been involved in outsourced manufacturing of oral dosage forms within the past 18 months
• Must play a role in gathering information about service providers, selecting service providers and/or managing contract manufacturing activities